Scale-up Pediatric Sedation Techniques

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200063099

Enrollment

Unknown

Registered

2022-08-30

Start date

2022-09-01

Completion date

Unknown

Last updated

2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child sedation

Interventions

Group 1 :Different doses of midazolam

Group 2:Different doses of dexmedetomidine

Eligibility

Sex/Gender

All

Age

No minimum to 6 Years

Inclusion criteria

Inclusion criteria: 1. Age 0-6 years old; 2. ASA classification I-II; 3. Under sedation, the brain was examined by MRI.

Exclusion criteria

Exclusion criteria: 1. Injuries to nasal and oral mucosa; 2. Severe upper respiratory infection; 3. History of allergy to sedative drugs.

Design outcomes

Primary

Measure	Time frame
Sedation success rate;Sedation induction time;Sedation time;Adverse effects;	—

Countries

China

Contacts

Public ContactLan Jiangli

Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region

70588175@qq.com+86 18977191748

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026